BIOTELUS - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 16,525 | 12,495 | 10,839 | 20,651 | 14,475 | 15,740 | 6,001 | 15,866 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | -20,249 | -17,337 | -5,193 | -42,043 | -20,867 | -20,039 | -14,997 | 10,976 |
| Equity | 631 | -16,708 | -21,900 | -63,943 | -84,810 | -104,849 | -119,846 | -108,870 |
| Liabilities | 157,225 | 155,429 | 169,050 | 163,625 | 158,547 | 148,501 | 146,460 | 151,995 |
| Non-current assets | 6,419 | 5,891 | 5,121 | 4,623 | 7,560 | 6,781 | 4,935 | 2,317 |
| Current assets | 151,392 | 132,777 | 141,964 | 94,884 | 65,953 | 36,753 | 21,653 | 40,808 |
| Total assets | 157,811 | 138,668 | 147,085 | 99,507 | 73,513 | 43,534 | 26,588 | 43,125 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 673 | 226 | - |
| Social insurance contributions | - | - | - | - | - | 194 | - | - |
|
Financial indicators
|
||||||||
| Revenue change y/y | +8.5% | -24.4% | -13.3% | +90.5% | -29.9% | +8.7% | -61.9% | +164.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -12.8% | -12.5% | -3.5% | -42.3% | -28.4% | -46.0% | -56.4% | 25.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -3209.0% | - | - | - | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -122.5% | -138.8% | -47.9% | -203.6% | -144.2% | -127.3% | -249.9% | 69.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 249.2 | - | - | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 4,837 | 4,165 | 3,613 | 7,289 | 6,204 | 5,724 | 2,770 | 7,933 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
BIOTELUS - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-05-18 | 2026-05-18 | 3.60 |
| 2026-05-17 | 2026-05-17 | 30.16 |
| 2024-04-23 | 2024-05-14 | 0.56 |
| 2024-02-19 | 2024-03-14 | 0.03 |
| 2024-01-16 | 2024-02-13 | 62.69 |
| 2022-02-17 | 2022-03-14 | 0.07 |
| 2022-01-31 | 2022-02-13 | 0.07 |
BIOTELUS - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
BIOTELUS, UAB (code 125916233) is a Private Limited Liability Company engaged in raising of sheep and goats. In the latest financial year, 2025, the company generated revenue of €15.9K and recorded net profit of €11.0K, corresponding to a profit margin of 69.2%. This marks a strong improvement from 2024, when revenue fell to €6.0K and the company posted a €15.0K loss, after a €20.0K loss in 2023. Over the two-year period from 2023 to 2025, revenue was broadly stable overall, up 0.8%, but performance improved materially in 2025 due to a return to profitability. At year-end 2025, total assets stood at €43.1K, equity remained negative at €108.9K, and liabilities amounted to €152.0K. Asset turnover was 0.37x, indicating limited revenue generation relative to the asset base. Revenue per employee was €7.9K and profit per employee was €5.5K. ROE should be interpreted cautiously because equity remained negative.